Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, a new study finds. In a study of US male veterans, investigators matched 1754 patients with ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

T-DXd outperformed physician’s choice of chemotherapy regardless of patients’ disease burden or time to progression on prior therapy.

A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital Medicine. Noting there are no personalized ...